Cardiopulmonary Exercise Testing Demonstrates the Impact of Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy
Circ Heart Fail 2022 Jun 29;[EPub Ahead of Print], R Badr Eslam, B Öztürk, R Rettl, CDJ Capelle, H Qin, C Binder, TM Dachs, L Camuz Ligios, F Duca, D Dalos, L Schrutka, F Alasti, J Kastner, G Vila, D BondermanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.